| Stage | DGII | % of rev | LMAT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $139M | 100.00% | $70M | 100.00% | DGII ×1.97 |
| Gross profit | $90M | 64.85% | $51M | 72.13% | LMAT +7.3pp |
| Operating income | $23M | 16.51% | $20M | 28.98% | LMAT +12.5pp |
| Pre-tax income | $21M | 15.33% | $22M | 31.53% | LMAT +16.2pp |
| Net income | $16M | 11.35% | $17M | 24.22% | LMAT +12.9pp |
| Stage | DGII | LMAT | Gap · A − B |
|---|---|---|---|
| Revenue | $139M100.00% | $70M100.00% | DGII ×1.97 |
| Gross profit | 64.85%$90M | 72.13%$51M | LMAT +7.3pp |
| Operating income | 16.51%$23M | 28.98%$20M | LMAT +12.5pp |
| Pre-tax income | 15.33%$21M | 31.53%$22M | LMAT +16.2pp |
| Net income |
| 11.35%$16M |
| 24.22%$17M |
| LMAT +12.9pp |
No disclosed counterparties: LMAT.
None